Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Russell Kerry Strong — Terns Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Russell Kerry Strong

Russell Kerry Strong

Chief Medical Officer at Terns Pharmaceuticals, Inc. · on record since Jun 10, 2022

Insider trading activity of Russell Kerry Strong

Transactions on record: 1; since Jul 6, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jul 6, 2022

Figures computed from official regulatory filings — methodology.

Companies where Russell Kerry Strong has traded

Terns Pharmaceuticals, Inc.1 tx · Jul 6, 2022

Track record of Russell Kerry Strong

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Russell Kerry Strong

Co-insiders of Russell Kerry Strong

ADEN MATTHEW JTerns Pharmaceuticals, Inc.
Azelby RobertTerns Pharmaceuticals, Inc.
Burroughs Amy L.Terns Pharmaceuticals, Inc.
Chase Jerry DTerns Pharmaceuticals, Inc.
FELLOWS DAVID ATerns Pharmaceuticals, Inc.
Gengos AndrewTerns Pharmaceuticals, Inc.
GORDON CARL LTerns Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Hopewell Resources Holdings LtdTerns Pharmaceuticals, Inc.

Jung Melita SunTerns Pharmaceuticals, Inc.

KINDLER JEFFREY BTerns Pharmaceuticals, Inc.

KRSTAJIC ALEKSANDERTerns Pharmaceuticals, Inc.

Kuriakose EmilTerns Pharmaceuticals, Inc.

LAV Aqua LtdTerns Pharmaceuticals, Inc.

LAV Biosciences Fund V, L.P.Terns Pharmaceuticals, Inc.

LOPEZ EDWARDTerns Pharmaceuticals, Inc.

Lu HongboTerns Pharmaceuticals, Inc.

LUSTENADER CAROL WTerns Pharmaceuticals, Inc.

MILLER MATTTerns Pharmaceuticals, Inc.

OrbiMed Advisors III LtdTerns Pharmaceuticals, Inc.

ORBIMED ADVISORS LLCTerns Pharmaceuticals, Inc.

OrbiMed Asia GP III, L.P.Terns Pharmaceuticals, Inc.

OrbiMed Capital GP VII LLCTerns Pharmaceuticals, Inc.

OrbiMed Genesis GP LLCTerns Pharmaceuticals, Inc.

Oriental Spring Venture LtdTerns Pharmaceuticals, Inc.

Quigley Jill M.Terns Pharmaceuticals, Inc.

Quirk ErinTerns Pharmaceuticals, Inc.

RAKIB SHLOMOTerns Pharmaceuticals, Inc.

RAKIB ZAKI DRTerns Pharmaceuticals, Inc.

RICHMAN MARKTerns Pharmaceuticals, Inc.

SABELLA DOUGLAS ATerns Pharmaceuticals, Inc.

SCHAEPE CHRISTOPHER JTerns Pharmaceuticals, Inc.

SLAVEN MARKTerns Pharmaceuticals, Inc.

SOLOMON LEWISTerns Pharmaceuticals, Inc.

SPEAKS HOWARD W JRTerns Pharmaceuticals, Inc.

Strauss David EricTerns Pharmaceuticals, Inc.

Sundaram Senthil VelTerns Pharmaceuticals, Inc.

Taylor Ann ElizabethTerns Pharmaceuticals, Inc.

Tripuraneni RadhikaTerns Pharmaceuticals, Inc.

Turner Heather DTerns Pharmaceuticals, Inc.

Vignola Mark J.Terns Pharmaceuticals, Inc.

Vivo Capital Fund VIII, L.P.Terns Pharmaceuticals, Inc.

Vivo Capital Surplus Fund VIII, L.P.Terns Pharmaceuticals, Inc.

Vivo Capital VIII, LLCTerns Pharmaceuticals, Inc.

Vivo Opportunity Fund Holdings, L.P.Terns Pharmaceuticals, Inc.

Vivo Opportunity Fund, L.P.Terns Pharmaceuticals, Inc.

Vivo Opportunity, LLCTerns Pharmaceuticals, Inc.

WOODROW DAVID MTerns Pharmaceuticals, Inc.

Yassini-Fard RouzbehTerns Pharmaceuticals, Inc.

Yoon Seokho BryanTerns Pharmaceuticals, Inc.

Zhong WeidongTerns Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Terns Pharmaceuticals, Inc.	Jul 6, 2022	AwardD	240,000	0.00 USD	$0	SEC